SINOPHARM (01099): The mid-term operating profit of Sinopharm Medical Equipment is 599 million yuan, a year-on-year decrease of 12.34%.
China National Pharmaceutical Group (01099) announced the six-month performance of China National Pharmaceutical Equipment for the period ending June 30, 2026. The company achieved operating revenue of 36.492 billion yuan (RMB, the same below), a year-on-year increase of 0.36%; operating profit of 599 million yuan, a year-on-year decrease of 12.34%; and comprehensive income attributable to the owners of the parent company of 287 million yuan, a year-on-year decrease of 2.56%.
SINOPHARM (01099) announced its performance for the six months ending on June 30, 2026. The company achieved operating revenue of 36.492 billion yuan (RMB, the same below), an increase of 0.36% year-on-year; operating profit of 599 million yuan, a decrease of 12.34% year-on-year; and comprehensive income attributable to owners of the parent company of 287 million yuan, a decrease of 2.56% year-on-year.
Related Articles
CHINA ORAL IND (08406) has completed the issuance of a total of 328 million subscription shares, raising approximately 18.29 million HKD.
SUN HUNG KAI CO (00086) will distribute an interim dividend of HK$0.13 per share on September 21.
YTO INTL EXP (06123): Wang Lixiu resigned as a non-executive director.
CHINA ORAL IND (08406) has completed the issuance of a total of 328 million subscription shares, raising approximately 18.29 million HKD.
SUN HUNG KAI CO (00086) will distribute an interim dividend of HK$0.13 per share on September 21.
YTO INTL EXP (06123): Wang Lixiu resigned as a non-executive director.
RECOMMEND
